Diabetic nephropathy (DN) is an inflammatory chronic disease. Macrophage infiltration via adhesion and migration ultimately determines the severity of DN. TREM-1(Triggering Receptor Expressed On Myeloid Cells 1) is essential for adhesion and migration capacity of macrophage. Our previous studies indicated that active vitamin D (VD) has renoprotective role via inhibiting macrophages infiltration. The current study aimed to investigate whether VD suppresses macrophages infiltration via inhabiting TREM-1 expression to reduce adhesion and migration. METHODS: Experimental rat model were established and random distributed into four groups as follows: NC, VD, DN and DN+VD (DN+ Calcitriol 0.1 lg•kg-1•d-1 by gavages). Animals were sacrificed respectively at 8w and 12w. Pathological changes in kidney tissue were detected and the expression of CD68 and TREM-1 were acquired by Immunohistochemistry stain and Western Blot. In vitro, RAW 264.7 cells were treated by high glucose with or without 10-8 mol/L 1,25(OH)2D3. TREM-1 siRNA and high expression plasmid of TREM-1 were explored to elucidate the underlying mechanism. The expression of TREM-1 and the ability of macrophage in adhesion and migration were examined separately by Western Blot, adhesion experiment and migration assay. RESULTS: (1) In DN group, the enlargement of glomerular surface area, expansion of glomerular mesangial matrix, number of macrophage with CD68+ and expression of TREM-1 protein were significantly increased in comparation with NC group(P<0.05), while above changes were markedly decreased in DN+VD group(P<0.05). (2) The capacity of adhesion and migration in macrophage and the amount of TREM-1 protein were obviously increased in HG group ,compared with NC group(P<0.05). (3) The number of macrophage adhesion and migration was notably reduced after TREM-1 siRNA intervention(P<0.05). VD significantly decreased the amount of macrophage adhesion and migration caused by high glucose(P <0.05). (4) Adhesion and migration ability of macrophage were remarkably increased via TREM-1 overexpression (P <0.05), and meanwhile VD inhibition of macrophage adhesion and migration induced by high glucose disappeared. CONCLUSIONS: VD can suppress the capacity of macrophage adhesion and migration via reducing the expression of TREM-1 and eventually inhibiting infiltration of macrophage in renal tissue of diabetic nephropathy rats.
INTRODUCTION AND AIMS:
Diabetic nephropathy (DN) is an inflammatory chronic disease. Macrophage infiltration via adhesion and migration ultimately determines the severity of DN. TREM-1(Triggering Receptor Expressed On Myeloid Cells 1) is essential for adhesion and migration capacity of macrophage. Our previous studies indicated that active vitamin D (VD) has renoprotective role via inhibiting macrophages infiltration. The current study aimed to investigate whether VD suppresses macrophages infiltration via inhabiting TREM-1 expression to reduce adhesion and migration. METHODS: Experimental rat model were established and random distributed into four groups as follows: NC, VD, DN and DN+VD (DN+ Calcitriol 0.1 lg•kg-1•d-1 by gavages). Animals were sacrificed respectively at 8w and 12w. Pathological changes in kidney tissue were detected and the expression of CD68 and TREM-1 were acquired by Immunohistochemistry stain and Western Blot. In vitro, RAW 264.7 cells were treated by high glucose with or without 10-8 mol/L 1,25(OH)2D3. TREM-1 siRNA and high expression plasmid of TREM-1 were explored to elucidate the underlying mechanism. The expression of TREM-1 and the ability of macrophage in adhesion and migration were examined separately by Western Blot, adhesion experiment and migration assay. RESULTS: (1) In DN group, the enlargement of glomerular surface area, expansion of glomerular mesangial matrix, number of macrophage with CD68+ and expression of TREM-1 protein were significantly increased in comparation with NC group(P<0.05), while above changes were markedly decreased in DN+VD group(P<0.05). (2) The capacity of adhesion and migration in macrophage and the amount of TREM-1 protein were obviously increased in HG group ,compared with NC group(P<0.05). (3) The number of macrophage adhesion and migration was notably reduced after TREM-1 siRNA intervention(P<0.05). VD significantly decreased the amount of macrophage adhesion and migration caused by high glucose(P <0.05). (4) Adhesion and migration ability of macrophage were remarkably increased via TREM-1 overexpression (P <0.05), and meanwhile VD inhibition of macrophage adhesion and migration induced by high glucose disappeared. CONCLUSIONS: VD can suppress the capacity of macrophage adhesion and migration via reducing the expression of TREM-1 and eventually inhibiting infiltration of macrophage in renal tissue of diabetic nephropathy rats. 
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INTRODUCTION AND AIMS: Empagliflozin, one of the sodium-glucose cotransporter 2 (SGLT2) inhibitors, has recently been reported to retard the progression of kidney disease in diabetic patients. Evidence from animal studies shows that it offers kidney benefits in better function, less hyperfiltration, less albuminuria and ameliorating pathology. However, little is known about the underlying mechanisms of these phenomenons. Glucose is known to produce oxidative stress in glomeruli and renal tubules and eventually leads to their mitochondrial damage. SGLT2 inhibitors are reported to attenuate inflammation and reduce cellular apoptosis in intestinal cells by regulating their reactive oxygen species production. In this study, we aimed to test the hypothesis that SGLT2 inhibitor offers renal protection via mitochondriadependent pathways. METHODS: Wild type C57BL/6 mice were induced into diabetes by high fat high sucrose (HFHS) diet. Immunohistochemistry was used to assay the alterations in the expressions of mitochondrial fusion/fission proteins in diabetic mice. Human proximal tubular cells (PTC), HK2 cells, were used as a cellular model to test the central hypothesis of this study. Transmission electron microscopy (TEM) and immunofluorescence were used to assay mitochondrial morphology. Western blots were used to examine the changes in the expression of mitochondrial fusion/fission proteins. TUNEL assay was used to examine the rescue effects of empagliflozin on cellular apoptosis. Flow cytometry was used to measure mitochondrial membrane potential and to quantify the intracellular oxidative stress. Quantitative RT-PCR was used to measure mitochondrial DNA content. ELISA was used to quantify mitochondrial ATP production. RESULTS: We found that mice fed with HFHS diet demonstrated down-regulation of mitochondrial fusion proteins and up-regulation of fission proteins in renal proximal tubules. By using TEM, we showed that glucose induced a shrinkage appearance of mitochondria. In human PTC, cells were susceptible to glucose-induced mitochondria fragmentation, and the fragmentation was rescued by empagliflozin. Western blots showed glucose induced up-regulation of Dynamin-related protein 1 (DRP1) and down-regulation of Mitofusion 1 (MFN1) and mitofusion 2 (MFN2). At the cellular level, empagliflozin was able to reduce glucose-induced cellular apoptosis. Furthermore, empagliflozin was able to restore mitochondrial ROS production, mitochondrial membrane potential, and to protect mitochondria from fragmentation. Empagliflozin could improve mitochondrial functions e.g. increasing in oxidative metabolism, ATP production, and increase mitochondrial DNA contents in high glucose treated HK2 cells. CONCLUSIONS: Our results suggested that SGLT2 inhibitor protected renal PTC from glucose-mediated injuries through a mitochondria dependent mechanism. This could be one of the novel mechanism explaining the renal benefits demonstrated in the landmark clinical trial.
INTRODUCTION AND AIMS:
Several reports have revealed that, in diabetic rodents, tubular reabsorption of albumin is decreased in superficial nephrons along with mild increase in albuminuria. However, changes in total amounts of filtered and reabsorbed albumin by all nephrons in diabetes remain unknown. Our recent transmission electron microscopy study showed that endocytosis-related organelles, such as endosomes, were rather enlarged and increased in S1 proximal tubules of diabetic mice with mild albuminuria at 10 weeks after streptozotocin (STZ) treatment of normal mice, suggesting that tubular albumin reabsorption may be enhanced in the early stage of diabetes. Megalin is expressed in apical membranes of proximal tubules and an essential receptor for albumin reabsorption. Previous studies reported that a number of megalin knockout mouse lines show various extent of albuminuria.The aim of this study is to measure the amount and change of total nephron albumin filtration and reabsorption in STZ-induced diabetic mice with mild albuminuiria by inducible megalin deletion system. METHODS: Megalin(lox/lox);Ndrg1-CreER T2 mice (iMegKO), which lose albumin reabsorption capacity in proximal tubules by tamoxifen (Tam) treatment, enable indirect measurement of total nephron albumin filtration and reabsorption through analysis of urine. For induction of diabetes, STZ was injected 8 weeks prior to Tam treatment (STZ;iMegKO). RESULTS: Megalin protein expression in the kidney was reduced by >90% both in non-STZ; and STZ;iMegKO mice. After Tam treatment, amounts of daily urinary albumin excretion (UAE) were elevated by 16-fold in non-STZ;iMegKO mice compared to non-STZ;control mice (total nephron albumin filtration in normoglycemia). These values were further increased by 1.9-fold by STZ treatment in parallel with hyperglycemia, and insulin treatment normalized albumin hyperfiltration. Consistently, glomerular Abstracts Nephrology Dialysis Transplantation iii100 | Abstracts
